Estudio en fase IV del test de diagnóstico molecular de cáncer de endometrio GynEC®-DX sobre muestras insuficientes o no concluyentes
Since 2015 La Paz University hospital (Madrid) has been leading a phase IV clinical study to evaluate the of GynEC®-DX in the biomarkers-guided surveillance of patients with Lynch syndrome. Preliminary results of this project, led by Drs. Javier de Santiago García and María Dolores Diestro Tejeda, have been presented at 33rd National Congress of the Gynecologic Oncology Section of the Spanish Society of Gynecology and Obstetrics (SEGO).
Estudio en fase IV del test de diagnóstico molecular de cáncer de endometrio GynEC®-DX sobre muestras insuficientes o no concluyentes
A multicenter study involving Jiménez Díaz Fundation (Madrid), Dexeus fundation (Barcelona), and the hospitals of Ntra Sra. de Candelaría (Tenerife), Henares (Madrid), Infanta Elena (Madrid) and Álvarez Buylla (Oviedo) has tested the capacity of GynEC®-DX to exploit endometrial aspirates from patients that had an inconclusive result in Anatomical Pathology.
The project, coordinated by Drs Francisco Javier Plaza Arranz and Raquel Sanz Baro, concluded that GynEC®-DX yields a conclusive result in 88.9% of the samples in which the pathologist could not obtain a diagnosis through histological analysis (Sanz, 2016).
Reference: Sanz Baro (2016) Estudio en fase IV del test de diagnóstico molecular de cáncer de endometrio GynEC®-DX sobre muestras insuficientes o no concluyentes. Doctoral thesis, Autonomous University of Madrid.